Germany further argues that Sovello was confronted to a substantial commercial risk, as it was still to demonstrate that the String-Ribbon technology could lead to industrially marketable products. The fact that Sovello had a sales agreement with Evergreen could not really reduce this risk because Evergreen was an SME itself and had no knowledge on the German market. The other shareholder, Q-Cells, had no experience in selling solar modules, as it only produced solar cells. Moreover, Q-Cells was also an SME [On 2 March 2005, the Commission concluded that Q-Cells was a SME, and approved a SME bonus for Q-Cells in its decision N 457/04 (OJ C 131, 28.5.2005, p. 11).] and had to concentrate its efforts on the commercialisation of its own output.
53 5. COMMENTS FROM THE GERMAN AUTHORITIES › 5.2. Typical SME handicaps of Sovello › 5.2.2. SME handicaps related to commercialization, Decision_act (EU) 2010/358
In forcesince 27 Jan 2010